April 11, 2024: Wegovy Lawsuit Strategy: Novo Nordisk Files Statement of the Case Wegovy manufacturer Novo Nordisk filed a statement of the case on April 9, 2024
The drug begins with 0.25mg per week during the initial month with a gradual rise in dosage to 1mg or 2.4mg depending on the response and tolerance
Zepbound, the brand name for Eli Lilly's tirzepatide, was approved by the FDA in 2023 for chronic weight management in adults with obesity or overweight with weight-related medical problems
Instead, contact your PlexusDx provider to adjust your dose, switch medications, or explore the Microdose GLP-1 Protocol ($129/mo), which uses lower starting doses for sensitive patients
The 60 mg vial is a compounded product
What is the L-carnitine dosage for weight loss